Seeking Alpha

Regenerative-medicine firm Athersys (ATHX) up 9.2% premarket as Maxim Group raises its price...

Regenerative-medicine firm Athersys (ATHX) up 9.2% premarket as Maxim Group raises its price target on the biopharma to $6.00 from $3.00. Shares closed yesterday at $1.31.
Comments (2)
  • Bob Dalton
    , contributor
    Comments (3) | Send Message
     
    Hilarious- Transparent attempt at stock manipulation. I here you and raise ATHX value to $9.00 per share. anyone else?
    5 Oct 2012, 09:48 AM Reply Like
  • Trainer
    , contributor
    Comments (136) | Send Message
     
    Few doubt that Biotech is the "next big thing". I wouldn't be so quick to dismiss Athersys (ATHX) if you have a few speculative dollars to risk and a lot of patience. The science is very sound and the potential market is enormous.
    5 Oct 2012, 10:02 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|